ARYA Sciences Acquisition (ARYAU) Stock Price, News & Analysis

Company Overview

ARYA Sciences Acquisition Corporation (OTCMKTS:ARYAU) is a special purpose acquisition company (SPAC) formed with the objective of identifying, acquiring, and merging with a life sciences or healthcare business. Sponsored by ARYA Sciences & Technology, the firm leverages a network of scientific and financial partners to support innovative biotech, pharmaceutical, and medical device enterprises seeking access to public markets. Since its inception in 2020, the company has pursued opportunities that align with its focus on novel therapeutics, diagnostics, and research‐enabling technologies.

The company’s core activities center on deal sourcing, due diligence, and structuring transactions that can accelerate growth in the target’s development pipeline. ARYA Sciences Acquisition brings strategic guidance, capital markets expertise, and operational support to portfolio companies, with an emphasis on unlocking value through technology transfer, regulatory strategy, and commercialization pathways. Its sponsor group includes seasoned biotech entrepreneurs, former pharmaceutical executives, and life sciences investors with deep domain knowledge.

While headquartered in New York City, ARYA Sciences Acquisition Corporation maintains a global outlook, with particular interest in high-growth innovation hubs across North America, Europe, and the Asia-Pacific region. The team evaluates cross-border ventures and collaborations, drawing on local partnerships to navigate regional regulatory frameworks and market dynamics. By combining global reach with sector specialization, the SPAC aims to connect breakthrough research with patient and provider communities worldwide.

The management team and board of directors bring decades of combined experience in drug development, clinical research, and capital markets. Their backgrounds span leading biotech start-ups, multinational pharmaceutical firms, and investment banks. This multidisciplinary leadership structure supports ARYA Sciences Acquisition Corporation’s mission to foster the next generation of life sciences companies through strategic public listings and growth initiatives.

Key Stats

• Today's Range: $19.50 to $19.69
• 50-Day Range: $19.51 to $19.51
• 52-Week Range: $10.45 to $22.00
• Volume: 1,000 shs
• Average Volume: 6,785 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ARYAU Stock Analysis - Frequently Asked Questions

How have ARYAU shares performed this year?

ARYA Sciences Acquisition's stock was trading at $19.51 at the start of the year. Since then, ARYAU shares have increased by 0.0% and is now trading at $19.51.

How do I buy shares of ARYA Sciences Acquisition?

Shares of ARYAU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Industrials
• Industry: Conglomerates
• Sub-Industry: Trading
• Current Symbol: OTCMKTS:ARYAU
• CIK: N/A
• Web: N/A
• Phone: 212-284-2300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A